These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

685 related items for PubMed ID: 19027010

  • 1. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
    Liu WH, Yeh SH, Lu CC, Yu SL, Chen HY, Lin CY, Chen DS, Chen PJ.
    Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
    [Abstract] [Full Text] [Related]

  • 2. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples.
    Xiong J, Yu D, Wei N, Fu H, Cai T, Huang Y, Wu C, Zheng X, Du Q, Lin D, Liang Z.
    FEBS J; 2010 Apr; 277(7):1684-94. PubMed ID: 20180843
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.
    Oncogene; 2012 Jul 12; 31(28):3357-69. PubMed ID: 22056881
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G, Barlati S.
    FEBS J; 2009 Jun 12; 276(11):2966-82. PubMed ID: 19490101
    [Abstract] [Full Text] [Related]

  • 5. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.
    Leivonen SK, Mäkelä R, Ostling P, Kohonen P, Haapa-Paananen S, Kleivi K, Enerly E, Aakula A, Hellström K, Sahlberg N, Kristensen VN, Børresen-Dale AL, Saviranta P, Perälä M, Kallioniemi O.
    Oncogene; 2009 Nov 05; 28(44):3926-36. PubMed ID: 19684618
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
    Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, Wong N.
    Gastroenterology; 2008 Jul 05; 135(1):257-69. PubMed ID: 18555017
    [Abstract] [Full Text] [Related]

  • 7. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
    Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J.
    Carcinogenesis; 2010 May 05; 31(5):766-76. PubMed ID: 19843643
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
    Yamamoto Y, Kosaka N, Tanaka M, Koizumi F, Kanai Y, Mizutani T, Murakami Y, Kuroda M, Miyajima A, Kato T, Ochiya T.
    Biomarkers; 2009 Nov 05; 14(7):529-38. PubMed ID: 19863192
    [Abstract] [Full Text] [Related]

  • 9. [The relationship between microRNA-18 and BTG2 in the carcinogenesis of hepatocellular carcinoma].
    Li Q, Wang G, Zhang ZM.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan 05; 17(1):42-5. PubMed ID: 19203451
    [Abstract] [Full Text] [Related]

  • 10. Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma.
    Li CL, Yeh KH, Liu WH, Chen CL, Chen DS, Chen PJ, Yeh SH.
    Int J Cancer; 2015 Feb 15; 136(4):761-70. PubMed ID: 24975878
    [Abstract] [Full Text] [Related]

  • 11. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L.
    Cancer Res; 2009 Jul 15; 69(14):5761-7. PubMed ID: 19584283
    [Abstract] [Full Text] [Related]

  • 12. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
    Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, Croce CM, Bolondi L, Negrini M.
    Cancer Res; 2007 Jul 01; 67(13):6092-9. PubMed ID: 17616664
    [Abstract] [Full Text] [Related]

  • 13. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
    Wang C, Song B, Song W, Liu J, Sun A, Wu D, Yu H, Lian J, Chen L, Han J.
    J Gastroenterol Hepatol; 2011 Nov 01; 26(11):1630-7. PubMed ID: 21557766
    [Abstract] [Full Text] [Related]

  • 14. MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.
    Wong QW, Ching AK, Chan AW, Choy KW, To KF, Lai PB, Wong N.
    Clin Cancer Res; 2010 Feb 01; 16(3):867-75. PubMed ID: 20103675
    [Abstract] [Full Text] [Related]

  • 15. High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma.
    Chung GE, Yoon JH, Myung SJ, Lee JH, Lee SH, Lee SM, Kim SJ, Hwang SY, Lee HS, Kim CY.
    Oncol Rep; 2010 Jan 01; 23(1):113-9. PubMed ID: 19956871
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer.
    Yoshimoto N, Toyama T, Takahashi S, Sugiura H, Endo Y, Iwasa M, Fujii Y, Yamashita H.
    Breast Cancer Res Treat; 2011 Nov 01; 130(1):331-9. PubMed ID: 21755340
    [Abstract] [Full Text] [Related]

  • 18. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
    Diao S, Zhang JF, Wang H, He ML, Lin MC, Chen Y, Kung HF.
    Proteomics; 2010 Oct 01; 10(20):3723-31. PubMed ID: 20859956
    [Abstract] [Full Text] [Related]

  • 19. The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras.
    Tsang WP, Kwok TT.
    Carcinogenesis; 2009 Jun 01; 30(6):953-9. PubMed ID: 19372139
    [Abstract] [Full Text] [Related]

  • 20. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.
    Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, Shimotohno K.
    Oncogene; 2006 Apr 20; 25(17):2537-45. PubMed ID: 16331254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.